Olaplex (NASDAQ:OLPX) General Counsel John Duffy Sells 34,824 Shares

Olaplex Holdings, Inc. (NASDAQ:OLPXGet Free Report) General Counsel John Duffy sold 34,824 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $1.26, for a total transaction of $43,878.24. Following the sale, the general counsel directly owned 633,202 shares of the company’s stock, valued at approximately $797,834.52. This represents a 5.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Olaplex Price Performance

OLPX stock traded up $0.01 during mid-day trading on Wednesday, reaching $1.31. The company’s stock had a trading volume of 1,130,247 shares, compared to its average volume of 1,786,861. The company has a current ratio of 4.58, a quick ratio of 4.00 and a debt-to-equity ratio of 0.40. The company’s 50 day moving average is $1.55 and its two-hundred day moving average is $1.36. Olaplex Holdings, Inc. has a fifty-two week low of $0.99 and a fifty-two week high of $1.84. The stock has a market cap of $876.91 million, a PE ratio of -131.00 and a beta of 2.24.

Olaplex (NASDAQ:OLPXGet Free Report) last issued its earnings results on Thursday, March 5th. The company reported $0.01 earnings per share for the quarter, hitting the consensus estimate of $0.01. The business had revenue of $105.12 million for the quarter, compared to analysts’ expectations of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.01 EPS. Equities research analysts expect that Olaplex Holdings, Inc. will post 0.1 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on OLPX shares. Evercore set a $2.50 price objective on Olaplex in a research note on Friday, March 6th. Telsey Advisory Group reiterated a “market perform” rating and set a $2.00 price target on shares of Olaplex in a report on Monday, March 2nd. Weiss Ratings reissued a “sell (d)” rating on shares of Olaplex in a research report on Thursday, January 22nd. Zacks Research raised shares of Olaplex from a “strong sell” rating to a “hold” rating in a report on Thursday, February 19th. Finally, Morgan Stanley set a $1.40 price objective on shares of Olaplex in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $1.88.

Get Our Latest Analysis on Olaplex

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Fund 1 Investments LLC acquired a new stake in Olaplex during the fourth quarter worth $1,023,000. Abel Hall LLC purchased a new stake in Olaplex in the fourth quarter valued at $27,000. Jump Financial LLC lifted its stake in shares of Olaplex by 193.7% in the 4th quarter. Jump Financial LLC now owns 29,800 shares of the company’s stock valued at $40,000 after purchasing an additional 19,653 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in shares of Olaplex by 284.7% in the 4th quarter. Russell Investments Group Ltd. now owns 1,909,836 shares of the company’s stock valued at $2,559,000 after purchasing an additional 1,413,423 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Olaplex by 9.5% during the 4th quarter. Barclays PLC now owns 245,088 shares of the company’s stock worth $328,000 after purchasing an additional 21,292 shares during the period. 87.37% of the stock is currently owned by hedge funds and other institutional investors.

About Olaplex

(Get Free Report)

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.

Featured Stories

Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.